Master Protocols in Rare Kidney Disease (RKD) Drug Development

• Leveraging Learnings from Oncology: Applying Basket, Umbrella, and Platform Trial Designs to Renal Disease
• Implementing Bayesian Clinical Trial Designs: Interpreting Recent Regulatory Guidance and Real-World Examples

Speakers:

Julie Lin

Senior Vice President, Clinical Development & Drug Safety/ Pharmacovigilance

Travere Therapeutics